Transplant Diagnostics Market Worth $645.0 Million by 2019

DALLAS, March 25, 2015 /PRNewswire/ --

According to a new market research report "Transplant Diagnostics Market by Technology (Serological, SSO- & SSP-PCR, Sanger Sequencing, NGS), Product (Instrument, Reagent, Software), End User (Hospitals, Transplant Centers, Academia), Application (Diagnostic, Research) - Global Forecasts to 2019", published by MarketsandMarkets, the global Transplant Diagnostics Market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $645.0 Million in 2019.

Browse 79 market data tables and 56 figures spread through 180 pages and in-depth TOC on "Transplant Diagnostics Market"

http://www.marketsandmarkets.com/Market-Reports/transplant-diagnostics-market-96374742.html
Early buyers will receive 10% customization on this report.

Based on the type of technology, the global Transplant Diagnostics Market is classified into two major segments, namely, non-molecular assay technology (serological and mixed lymphocyte culture assay) and molecular assay technology (PCR and sequencing-based techniques) segments. Moreover, based on type of products, the global Transplant Diagnostics Market is classified into three product segments, namely, instruments, reagents and consumables, and software and services.

The global Transplant Diagnostics Market is further classified into three end user segments, namely hospitals and transplant centers, research laboratories and academic institutes, and commercial service providers. Additionally, the global Transplant Diagnostics Market is segmented based on applications into diagnostic applications and research applications.

Inquiry before Buying:  http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=96374742

As of 2014, North America holds the largest share of the Transplant Diagnostics Market, followed by Europe. However, the Asia-Pacific market is expected to grow at highest CAGR during 2014 to 2019. A number of factors such as increasing focus of global life science companies in emerging markets, growing public and private support to develop novel HLA typing technologies, and strengthening healthcare infrastructure across the APAC are stimulating the growth of the Transplant Diagnostics Market in the Asia-Pacific region.

Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche, Ltd. (Switzerland), Illumina, Inc. (U.S.), Immucor, Inc. (U.S.), Linkage Biosciences (U.S.), Olerup Ssp Ab (Norway), Qiagen N.V. (Netherlands), Sigma-Aldrich (U.S.), and Thermo Fisher Scientific Inc. (U.S.) are the major players in the global Transplant Diagnostics Market.

Browse Related Reports: 

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018

http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017

http://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html

About MarketsandMarkets  

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain  @http://www.marketsandmarkets.com/Subscription.html

Contact: 

Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets